BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 23284917)

  • 1. Loss of P2X7 receptor plasma membrane expression and function in pathogenic B220+ double-negative T lymphocytes of autoimmune MRL/lpr mice.
    Le Gall SM; Legrand J; Benbijja M; Safya H; Benihoud K; Kanellopoulos JM; Bobé P
    PLoS One; 2012; 7(12):e52161. PubMed ID: 23284917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The accumulation of B220+ CD4- CD8- (DN) T cells in C3H-lpr/lpr mice is not accelerated by the stimulation of CD8+ T cells or B220+ DN T cells with staphylococcal enterotoxin B and occurs independently of V beta 8+ T cells.
    Giese T; Davidson WF
    Int Immunol; 1995 Aug; 7(8):1213-23. PubMed ID: 7495728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2X7 purinergic receptor plays a critical role in maintaining T-cell homeostasis and preventing lupus pathogenesis.
    Mellouk A; Hutteau-Hamel T; Legrand J; Safya H; Benbijja M; Mercier-Nomé F; Benihoud K; Kanellopoulos JM; Bobé P
    Front Immunol; 2022; 13():957008. PubMed ID: 36248812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalities.
    Aicher WK; Fujihashi K; Taguchi T; McGhee JR; Yamamoto M; Eldridge JH; Gay S; Kiyono H
    Eur J Immunol; 1992 Jan; 22(1):137-45. PubMed ID: 1346108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B220+ double-negative T cells suppress polyclonal T cell activation by a Fas-independent mechanism that involves inhibition of IL-2 production.
    Hamad AR; Mohamood AS; Trujillo CJ; Huang CT; Yuan E; Schneck JP
    J Immunol; 2003 Sep; 171(5):2421-6. PubMed ID: 12928389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in Cellular Responses of Mouse T Cells to Adenosine-5'-Triphosphate Stimulation Do Not Depend on P2X7 Receptor Expression Levels but on Their Activation and Differentiation Stage.
    Safya H; Mellouk A; Legrand J; Le Gall SM; Benbijja M; Kanellopoulos-Langevin C; Kanellopoulos JM; Bobé P
    Front Immunol; 2018; 9():360. PubMed ID: 29535730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
    Benihoud K; Bonardelle D; Bobé P; Kiger N
    Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
    Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
    J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic rearranged T cell receptor gene inhibits lymphadenopathy and accumulation of CD4-CD8-B220+ T cells in lpr/lpr mice.
    Mountz JD; Zhou T; Eldridge J; Berry K; Blüthmann H
    J Exp Med; 1990 Dec; 172(6):1805-17. PubMed ID: 1701823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
    Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
    J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas-independent T-cell apoptosis by dendritic cells controls autoimmune arthritis in MRL/lpr mice.
    Izawa T; Kondo T; Kurosawa M; Oura R; Matsumoto K; Tanaka E; Yamada A; Arakaki R; Kudo Y; Hayashi Y; Ishimaru N
    PLoS One; 2012; 7(12):e48798. PubMed ID: 23300516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the existence of distinct heterogeneity among the peripheral CD4-CD8- T cells from MRL-lpr/lpr mice based on the expression of the J11d marker, activation requirements, and functional properties.
    Kakkanaiah VN; Nagarkatti M; Nagarkatti PS
    Cell Immunol; 1990 May; 127(2):442-57. PubMed ID: 2139366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proliferative in vivo activities of lpr double-negative T cells and the primary role of p59fyn in their activation and expansion.
    Balomenos D; Rumold R; Theofilopoulos AN
    J Immunol; 1997 Sep; 159(5):2265-73. PubMed ID: 9278315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8
    Mellouk A; Bobé P
    FASEB J; 2019 Mar; 33(3):3225-3236. PubMed ID: 30383448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional studies of adhesion molecules on CD4-CD8- double negative T cells of autoimmune MRL/Mp-lpr/mice].
    Wang W
    Hokkaido Igaku Zasshi; 1993 Sep; 68(5):755-66. PubMed ID: 8225181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In CD8+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes.
    Giese T; Davidson WF
    J Immunol; 1995 May; 154(10):4986-95. PubMed ID: 7537297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr.
    Drappa J; Brot N; Elkon KB
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10340-4. PubMed ID: 7694292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Tesch G; Kinoshita K; Maron R; Weiner HL; Kelley VR
    J Immunol; 1999 Dec; 163(12):6884-91. PubMed ID: 10586090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the existence of two parallel differentiation pathways in the thymus of MRL lpr/lpr mice.
    Matsuzaki Y; Pannetien C; Kanagawa O; Gachelin G; Nakauchi H
    J Immunol; 1992 Aug; 149(3):1069-74. PubMed ID: 1378863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a B220+ lymphoid cell subpopulation with immune modulatory functions in nasal-associated lymphoid tissues.
    Rharbaoui F; Bruder D; Vidakovic M; Ebensen T; Buer J; Guzmán CA
    J Immunol; 2005 Feb; 174(3):1317-24. PubMed ID: 15661888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.